A) A skin condition. B) A muscle abnormality. C) A type of blood cell. D) An abnormal growth of tissue in bone.
A) Only from the bone itself. B) From the liver. C) From the brain. D) From cancers in another part of the body such as lung, breast, thyroid, kidney, and prostate.
A) A sprained ankle. B) A broken rib. C) A pathologic fracture. D) A dislocated shoulder.
A) Coughing and sneezing. B) Fatigue, fever, weight loss, anemia, and nausea. C) Blurred vision. D) Hearing loss.
A) By blood pressure measurement. B) By X-ray and other radiological tests such as CT scan, MRI, PET scan, and bone scintigraphy. C) By urine color analysis. D) By a physical exam alone.
A) Blood sugar levels. B) Hemoglobin A1c. C) Cholesterol levels. D) Complete blood count, inflammatory markers, serum electrophoresis, PSA, kidney function, and liver function.
A) Bence Jones protein. B) Glucose. C) Protein levels. D) Urea.
A) A physical therapy session. B) A blood transfusion. C) A dietary consultation. D) A biopsy for histological evaluation.
A) Chondrosarcoma. B) Ewing sarcoma. C) Osteosarcoma. D) Non-ossifying fibroma.
A) 68%. B) 85%. C) 90%. D) 50%.
A) In a foot bone in South Africa. B) In a rib bone in India. C) In a skull bone in China. D) In a hand bone in Egypt.
A) Tumors that originate in the brain. B) Tumors that originate in bone or from bone-derived cells and tissues. C) Tumors that originate in the lungs. D) Tumors that originate in the liver.
A) Tumors that originate in the skin. B) Tumors that originate in the heart. C) Tumors that originate in other sites and spread to the skeleton. D) Tumors that originate in the kidneys.
A) Prostate, breasts, lungs, thyroid, and kidneys. B) Lungs, liver, and pancreas. C) Stomach, colon, and bladder. D) Skin, brain, and ovaries.
A) Ewing sarcoma. B) Osteochondroma. C) Osteosarcoma. D) Chondrosarcoma.
A) Bone sarcoma. B) Metastatic tumor. C) Benign tumor. D) Hamartoma.
A) Spine and pelvis. B) Distal femur and proximal tibia. C) Chest and abdomen. D) Shoulder and elbow.
A) Leukemia. B) Multiple myeloma. C) Thrombocytopenia. D) Lymphoma.
A) In the lungs. B) In the liver. C) In the midline of the sacrum, coccyx, or both. D) In the kidneys.
A) Using specialized studies like genetic and immunohistochemical tests. B) Using only physical exams. C) Using only blood tests. D) Using only X-rays.
A) Ewing sarcoma B) Osteosarcoma C) Fibrosarcoma D) Chondrosarcoma
A) Improved reflexes B) Increased muscle tone C) Neurological signs D) Enhanced coordination
A) They are always benign B) They are rarely ever curable C) They are easily treated with medication D) They do not require diagnosis
A) Oral chemotherapy B) Intravenous chemotherapy C) Topical chemotherapy D) Intra-arterial protocol with serial arteriogram
A) When tumor response is <50% necrosis B) After 6 months of treatment C) Immediately after chemotherapy starts D) When tumor response has reached >90% necrosis
A) Non-hormonal bisphosphonates B) Chemotherapy drugs C) Radiotherapy D) Strontium-89 chloride
A) Joint preservation surgical reconstruction B) Chemotherapy C) Radiotherapy D) Limb amputation
A) Pain medication B) External beam radiation therapy C) Chemotherapy D) Surgical resection
A) The outcome is generally good. B) The outcome is always fatal. C) The outcome is uncertain. D) The outcome is poor.
A) Yes, all benign tumors become cancerous. B) Yes, some types may eventually become malignant. C) No, they remain benign forever. D) No, they never become cancerous.
A) Most patients achieve a cure, but it depends on various factors. B) Cure is impossible. C) All patients are cured. D) Cure rate is independent of tumor type, location, and size.
A) Around 10%. B) Around 50%. C) Around 5%. D) Around 0.2%. |